MBio Diagnostics, Inc. Announces CEO Chris Myatt to Present at Biotech Showcase
(firmenpresse) - BOULDER, CO -- (Marketwire) -- 01/10/12 -- MBio Diagnostics, Inc. announced that its CEO, Christopher Myatt, Ph.D., will present at the BioTech Showcase 2012 in San Francisco on January 11th at 9:00 a.m. PST at San Francisco's Parc 55 Wyndham hotel. Dr. Myatt will present an overview on the Company including its accomplishments in 2011 and its focus for 2012 and the future.
MBio Diagnostics, Inc. () is a privately held clinical diagnostics and life sciences technology company based in Boulder, CO. MBio is developing a suite of simple, multiplexed diagnostic tests using its proprietary LightDeck™ technology. Initial product development focuses on high impact infectious diseases, including HIV, hepatitis, and influenza. The company's product development is aimed at decentralized testing, from the clinic to the home.
For more information visit MBio at or contact:
Christopher J. Myatt, Ph.D.
MBio Diagnostics, Inc.
Phone: 303-952-2815
E-mail:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.01.2012 - 20:02 Uhr
Sprache: Deutsch
News-ID 102916
Anzahl Zeichen: 0
contact information:
Town:
BOULDER, CO
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 227 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MBio Diagnostics, Inc. Announces CEO Chris Myatt to Present at Biotech Showcase"
steht unter der journalistisch-redaktionellen Verantwortung von
MBio Diagnostics (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
